Phakic Intraocular Lens Implantation and Corneal Crosslinking
Several reports have demonstrated the benefits of PIOL implantation in conjunction with CCL. In patients with keratoconus, toric posterior chamber PIOLs and foldable iris-claw PIOLs both have shown improved refractive outcomes with good safety (no loss of BCVA and no significant decrease in endothelial cell count). Neither of these PIOLs has been approved by the US FDA.
Kymionis GD, Grentzelos MA, Portaliou DM, et al. Corneal collagen cross-linking (CXL) combined with refractive procedures for the treatment of corneal ectatic disorders: CXL plus. J Refract Surg. 2014;30(8):566–576.
Excerpted from BCSC 2020-2021 series: Section 13 - Refractive Surgery. For more information and to purchase the entire series, please visit https://www.aao.org/bcsc.